KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Short-term Investments: 2020-2025

Historic Short-term Investments for Hims & Hers Health (HIMS) over the last 5 years, with Sep 2025 value amounting to $284.0 million.

  • Hims & Hers Health's Short-term Investments rose 220.67% to $284.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $284.0 million, marking a year-over-year increase of 220.67%. This contributed to the annual value of $79.7 million for FY2024, which is 35.92% down from last year.
  • Per Hims & Hers Health's latest filing, its Short-term Investments stood at $284.0 million for Q3 2025, which was up 1,317.49% from $20.0 million recorded in Q2 2025.
  • Over the past 5 years, Hims & Hers Health's Short-term Investments peaked at $284.0 million during Q3 2025, and registered a low of $20.0 million during Q2 2025.
  • Moreover, its 3-year median value for Short-term Investments was $98.4 million (2024), whereas its average is $114.5 million.
  • Over the last 5 years, Hims & Hers Health's Short-term Investments had its largest YoY gain of 220.67% in 2025, and its largest YoY loss of 79.56% in 2025.
  • Hims & Hers Health's Short-term Investments (Quarterly) stood at $175.5 million in 2021, then fell by 24.30% to $132.9 million in 2022, then decreased by 6.42% to $124.3 million in 2023, then tumbled by 35.92% to $79.7 million in 2024, then spiked by 220.67% to $284.0 million in 2025.
  • Its last three reported values are $284.0 million in Q3 2025, $20.0 million for Q2 2025, and $48.9 million during Q1 2025.